Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
5
×
national blog main
boston blog main
boston top stories
national top stories
san francisco blog main
boston
clinical trials
san diego blog main
san diego top stories
startups
acute myeloid leukemia
adverum biotechnologies
ally bridge group
alnylam pharmaceuticals
ambit biosciences
athena countouriotis
beijing
big data analytics
biobucks
biotech ipos
blackrock
brett zbar
brii bio
brii biosciences
bristol-myers squibb
calistoga pharmaceuticals
car-t immunotherapy
casdin capital
checkpoint inhibitors
china
cormorant asset management
daiichi sankyo
deals
diabetic nephropathy
dyne therapeutics
eventide asset management
fda
focal segmental glomerulosclerosis
What
drug
5
×
million
5
×
medicines
new
raised
therapeutics
biotech
cancer
company
genetic
ipo
pipeline
year
adding
adds
alliance
analysis
areas
athena
bets
bio
biosciences
bio’s
boost
brii
bring
brings
ceo
chief
countouriotis
develop
developing
disease
diseases
disorders
dyne
dyne’s
earlier
employing
expensive
Language
unset
Current search:
drug
×
" life sciences "
×
million
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push